
HEXO Corp. HEXO
Annual report 2022
added 12-23-2023
HEXO Corp. P/S Ratio 2011-2026 | HEXO
Annual P/S Ratio HEXO Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.719 | 5.49 | 28.5 | - | 390 | 533 | 258 K | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 258 K | 0.719 | 43.1 K |
P/S Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | ||
|
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
4.24 | - | - | $ 2.06 B | ||
|
Canopy Growth Corporation
CGC
|
0.528 | $ 1.19 | 1.71 % | $ 128 M | ||
|
China Pharma Holdings
CPHI
|
1 | $ 0.61 | - | $ 10.7 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 4.07 | 3.83 % | $ 57.2 M | ||
|
Cronos Group
CRON
|
77.6 | $ 2.74 | -0.18 % | $ 1.42 B | ||
|
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | ||
|
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | ||
|
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B | ||
|
Harrow Health
HROW
|
2.67 | $ 52.5 | -0.54 % | $ 1.71 B | ||
|
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | ||
|
Emergent BioSolutions
EBS
|
0.132 | $ 11.16 | 1.82 % | $ 571 M | ||
|
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M | ||
|
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | ||
|
Evolus
EOLS
|
3.33 | $ 4.37 | 1.63 % | $ 271 M | ||
|
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
4.82 | $ 1.44 | 1.41 % | $ 402 M | ||
|
Jupiter Wellness
JUPW
|
118 | - | - | $ 33.6 M | ||
|
Pacira BioSciences
PCRX
|
5.13 | $ 23.61 | 0.85 % | $ 1.09 B | ||
|
Bausch Health Companies
BHC
|
0.386 | $ 6.16 | 2.33 % | $ 2.25 B | ||
|
Sundial Growers
SNDL
|
0.0158 | $ 1.55 | -0.32 % | $ 3.37 M | ||
|
Tilray
TLRY
|
1.9 | $ 7.97 | 0.6 % | $ 4.93 B | ||
|
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | ||
|
Organogenesis Holdings
ORGO
|
0.86 | $ 4.07 | 0.99 % | $ 536 M | ||
|
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | ||
|
Perrigo Company plc
PRGO
|
0.905 | $ 14.41 | -1.37 % | $ 1.98 B | ||
|
Aurora Cannabis
ACB
|
3.73 | $ 3.85 | 1.58 % | $ 86.3 M | ||
|
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | ||
|
Rockwell Medical
RMTI
|
0.424 | $ 0.91 | -3.58 % | $ 21.2 M | ||
|
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
0.434 | $ 11.84 | -0.84 % | $ 841 M | ||
|
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 2.9 | 2.11 % | $ 3.6 M | ||
|
SCYNEXIS
SCYX
|
0.502 | $ 0.77 | -1.72 % | $ 36.8 M | ||
|
Veru
VERU
|
6.39 | $ 2.65 | 1.56 % | $ 357 M | ||
|
TherapeuticsMD
TXMD
|
18.4 | $ 2.22 | -1.33 % | $ 23.2 M | ||
|
cbdMD
YCBD
|
0.0863 | $ 0.92 | -1.1 % | $ 3.97 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
895 | - | - | $ 55.5 M | ||
|
Viatris
VTRS
|
0.837 | $ 16.2 | 0.84 % | $ 19.6 B |